Aldosteronism

"Primary Aldosteronism (PA) is defined as non-suppressible hyper secretion of aldosterone by adrenal glands, with consequent suppression of plasma renin activity. It was described by Jerome Conn in 1955. It is said to be an under diagnosed and important secondary endocrine cause of hypertension, and is one of the few potentially curable causes of hypertension using both medical and surgical interventions. The most common subtypes of PA are bilateral adrenal hyperplasia (60%) and aldosterone-producing adenoma (30%). Other rarer causes include adrenal carcinoma (rare) and glucocorticoid suppressible hyperaldosteronism (rare). The prevalence of PA has been reported to be 1-14% in the general hypertensive population and as high as 20% in specialist referral populations with resistant hypertension". Journal of Steroids & Hormonal Science is an official journal of OMICS group international that publishes the articles related to Primary Aldosteronism. The peer review followed by Journal of Steroids & Hormonal Science is single blind peer review process. This sort of review process will enable the authors to make the required manipulations and improve the quality of their work as per the experts opinion

• Share this page
• 
• 
• 
• 
• 
• 

Last date updated on September, 2024